SCHEMBL17820944

SCHEMBL17820944

O=C(O)Nc1ccc2c(c1)Cc1c(F)ccc(Br)c1O2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.40
NPC1 O15118 8/20 0.34
RAB9A P51151 8/20 0.34
KMT2A Q03164 4/20 0.34
LMNA P02545 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
CASP3 P42574 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
NFKB1 P19838 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
HTT P42858 2/20 0.34
TP53 P04637 4/20 0.34
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
HPGD P15428 1/20 0.32
ALDH1A1 P00352 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17827828 0.84 RORC (0.41)
SCHEMBL17820091 0.82 POLB (0.36) MAOBNPC1RAB9AKMT2ALMNA
SCHEMBL17819807 0.80 SLC1A3 (0.37) MAOBNPC1RAB9AKMT2AMEN1
SCHEMBL17820794 0.79 RAB9A (0.39) NPC1RAB9AKMT2ALMNAMEN1
SCHEMBL17819629 0.76 MAPKAPK2 (0.42) NPC1RAB9ALMNASMN1; SMN2
SCHEMBL17820170 0.76 RAB9A (0.40) NPC1RAB9AKMT2AMAPTCASP3
SCHEMBL17820007 0.74 TRPM8 (0.40) NPC1RAB9AKMT2AMEN1MAPT
SCHEMBL17820630 0.73 KMT2A (0.41) RAB9AKMT2ALMNAMEN1MAPT
SCHEMBL4117988 0.70 IDO1 (0.48) NPC1RAB9AKMT2ALMNAMEN1
SCHEMBL1137180 0.70 MAOB (0.51) MAOBNPC1RAB9AKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3042900-B1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORP (JP) 2020-09-23 EP disclosed
US-9586951-B2 Morpholine derivative or salt thereof FUJIFILM CORPORATION (JP) 2017-03-07 US disclosed
EP-3042900-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF Fujifilm Corporation (JP) 2016-07-13 EP disclosed
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160168139-A1 NOVEL MORPHOLINE DERIVATIVE OR SALT THEREOF PRMT7, RBBP7, RER1 MAOB 3143/4885NPC1 3926/4885RAB9A 757/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.